reports
Moody's announces completion of a periodic review of ratings of Bio-Ra...
Moody's Investors Service (Moody's) has completed a periodic review of the ratings of Bio-Rad Laboratories, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 2 February 2024 in which Moody's reassessed the appropriateness of the...
- Sid Rajeev
Biome Grow Inc. (CSE: BIO) – Q3-2019 Revenue Growth Below Expectatio...
Fundamental Research Corp has issued a report entitled “Biome Grow Inc. (CSE: BIO) – Q3-2019 Revenue Growth Below Expectations / Distribution Channel to Six Provinces in Canada – FINAL REPORT†and dated January 10, 2020. The full report is now at Key Highlights  For Q3-2019, Biome Grow Inc. (“Biomeâ€, “companyâ€) reported revenue of $1.44 million, a QoQ increase of 7%. The company shipped approximately 192 kg of dried cannabis flower at an average selling price per gram of $...
A director sold 8,940 shares at 28.500EUR and
A director at Biotest Ag sold 8,940 shares at 28.500EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.